 LA JOLLA, Calif., Jan. 29, 2021 GLOBE NEWSWIRE -- Artelo Biosciences, Inc. NASDAQ: ARTL, a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced that it will be presenting at the LSX World Congress to be held virtually between February 1-5, 2021. 